This section of the Allergic Rhinitis Knowledge Centre contains a comprehensive overview of the disease, covering the epidemiology, pathophysiology and comorbidities; the latest diagnostic techniques, including the importance of differential diagnoses; how to effectively manage allergic rhinitis using algorithms and integrated care pathways; and the treatment section, which aims to inform about the wide range of therapies available and the unmet need. Click these links, the sections below or just continue scrolling down, the next page will load automatically.
Featuring details on ARIA guidelines, the pathophysiological response of sensitisation and early- and late-phase reaction, symptoms such as rhinorrhoea and nasal itching and comorbidities including asthma and migraine.
Explore the tools and techniques to aid diagnosis of allergic rhinitis, such as skin and IgE tests, and questionnaires asking 'Does you patient have - nasal hyperactivity, sneezing, itchy nose'. Disease severity should also be classified according to the ARIA guidelines.
Highlighting the Allergic Rhinitis Control Test (ARCT), Rhinitis Control Assessment Test (RCAT) and the Visual Analog Scale (VAS), the treatment algorithm MACVIA-CDSS, and details of integrated care pathways such as the MASK-rhinitis ICP.
A wide range of treatments are available, and their combinations, such as antihistamines, corticosteroids, anticholinergics, leukotriene receptor antagonists, cromones. Professor Jean Bousquet discuss the need for faster and more effective treatments.